Skip to main content
. 2016 Aug 3;11:68. doi: 10.1186/s13000-016-0518-y

Table 2.

Overall survival (OS) and disease-free survival (DFS) according to DEF6/p16 and DEF6/p53 co-expressions

OS (SE) 95 % CI Median (SE) (95 % CI) P-value DFS (SE) 95 % CI Median (SE) (95 % CI) P-value
DEF6/p16 co-expression
 DEF6-negative/
 p16-negative
75 (11) 53–98 90 (30)
30–149
0.027* 75 (11) 52–98 90 (30)
30–149
0.023*
 DEF6-negative/
 p16-positive
54 (16) 22–86 48 (30)
0–107
54 (16) 22–86 48 (30)
0–107
 DEF6-postive/
 p16-negative
41 (10) 22–61 27 (10)
6–47
39 (9) 19–58 27 (9)
8–45
 DEF6-positive/
 p16-positive
32 (6) 19–45 21 (4)
12–30
32 (6) 19–44 19 (3)
12–25
DEF6/p53 co-expression
 DEF6-negative
 /p53 (scores 1 and 2)
73 (10) 52-93 72 (20)
31-113
0.031* 73 (10) 52-93 72 (20)
31-113
0.028*
 DEF6-negative
 /p53 (scores 0 and 3)
64 (17) 30–99 76 (79)
0–230
64 (17) 30–97 76 (79)
0–230
 DEF6-postive
 /p53 (scores 1 and 2)
48 (11) 26–70 48 (25)
0–97
44 (10) 22–65 31 (16)
0–62
 DEF6-positive
 /p53 (scores 0 and 3)
29 (6) 16–41 19 (2)
13–24
28 (6) 16–41 17 (1)
14–19

SE, Standard error; CI, confidence interval

*significant difference

Log-rank test

DEF6 positive: Scores 2 and 3; DEF6 negative: Scores 0 and 1

p16 positive: Scores 2 and 3; p16 negative: Scores 0 and 1